# Element Solutions Inc: Form 10-Q for the period ended Sep 30, 2018

- Company: [Element Solutions Inc](/companies/esi.md) (CIK 1590714)
- Form: 10-Q
- Filed: 2018-11-01
- Accepted by EDGAR: Nov 1, 2018, 16:11 ET
- Period: 2018-09-30
- Accession: 0001590714-18-000109
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590714/000159071418000109/pah10-q2018930document.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590714/000159071418000109/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $488.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.48bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $278.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $847.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $209.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $635.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-07-01 to 2018-09-30 | $10.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-01-01 to 2018-09-30 | $33.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-07-01 to 2018-09-30 | $139.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-01-01 to 2018-09-30 | $424.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $59.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $177.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | −$18.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $21.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2018-01-01 to 2018-09-30 | −$356.1m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-30 | −$1.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-30 | −$1.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | −$1.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | −$1.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-30 | 288,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-30 | 288,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | −$26.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $19.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-09-30 | $252.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $2.47bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $9.39bn | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $1.13bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-09-30 | $7.28bn | us-gaap:Liabilities |
| Current portion of debt | at 2018-09-30 | $9.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-09-30 | $2.05bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 37,405 characters.

*This Management's Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the unaudited interim Condensed Consolidated Financial Statements and related notes included in this Quarterly Report, and the Consolidated Financial Statements, related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations section and other disclosures contained in our 2017 Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under "Forward-Looking Statements” and in Part II, Item 1A, "Risk Factors" of this Quarterly Report as well as in Part I, Item 1A, "Risk Factors" of our 2017 Annual Report.*

### Overview

#### Our Business

Platform, incorporated in Delaware in January 2014, is a global and diversified producer of high technology specialty chemical products. Our business involves the blending of a number of key ingredients to produce proprietary formulations. Utilizing our strong industry insight, process know-how, and creative research and development, we partner with our customers to provide innovative and differentiated solutions that are integral to their finished products. We operate in a wide variety of attractive niche markets across multiple industries, including automotive, electronics, graphics, and offshore oil and gas production and drilling, and we believe that the majority of our operations hold strong positions in the product markets they serve. Our product innovations and product extensions are expected to continue to drive sales growth in both new and existing markets, while also expanding margins by continuing to offer high customer value propositions.

We have leading market positions in niche segments of high-growth markets and continually seek opportunities to grow and enhance our strategic position by pursuing inorganic initiatives and focusing on specialty chemical businesses or assets within existing or complementary end-markets, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing resources to research and development, offering highly-technical sales and customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially prudent.

We generate revenue through the formulation and sale of our dynamic chemistries. In addition, we provide highly-technical service to our customers through our extensive global network of specially-trained service personnel. Our personnel follow up closely with our customers to ensure that the functional performance of our intricate chemical composition is maintained as intended and that these products are applied safely and effectively. Our specialty chemicals and processes are seen as integral to our customer’s product performance. We leverage these close customer relationships to execute our growth strategy and identify opportunities for new products. These new products are developed and created by drawing upon our intellectual property portfolio and technical expertise. We believe that our customers place significant value on our brands, which we capitalize on through innovation, product leadership and customer service.

#### Our Operations

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. As discussed in Note 4, *Discontinued Operations*, to the unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, the Agricultural Solutions segment met the requirements to be classified as discontinued operations. As a result, the Agricultural Solutions' operations have been excluded from the segment description below.

**Performance Solutions** - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, electronics, commercial packaging and printing, and oil and gas production and drilling. Its products include surface and coating materials, water-based hydraulic control fluids, and photopolymers. In conjunction with the sale of its products, the segment provides extensive technical service and support when necessary to ensure superior performance of their application. While the segment's dynamic chemistries typically represent only a small portion of its customers’ costs, we believe that they are critical to its customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for its customers to change suppliers and allow it to retain customers and maintain its market positions.

The segment focuses on attractive niche markets, which we believe will grow faster than the diverse end-markets we serve. It provides specialty chemical solutions through the following five businesses:

|  |  |
| --- | --- |
| Assembly Solutions: | The business develops, manufactures and sells innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. |
| Electronics Solutions: | The business designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of printed circuit boards and other electronic components they manufacture. |
| Industrial Solutions | The business' dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. |
| Graphics Solutions: | The business produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. |
| Offshore Solutions: | The business produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. |

### Announced Arysta Sale

#### Discontinued Operations Resulting from the Announced Arysta Sale

On July 20, 2018, we entered into the Arysta Sale Agreement to sell our Agricultural Solutions business, which consists of Arysta and its subsidiaries, to UPL for $4.20 billion in cash, subject to adjustments. As a result of entering into the Arysta Sale Agreement, the Agricultural Solutions business is being reported as discontinued operations in this Quarterly Report.

We recorded an estimated asset impairment loss of $376 million in the third quarter of 2018 as the carrying value of the Agricultural Solutions' business exceeded its estimated fair value, less costs to sell, primarily due to the recognition of foreign currency translation adjustments previously recorded in Accumulated Other Comprehensive Loss within Stockholders’ Equity. The estimated impairment loss reflects our best estimate of the amount of the charge at this time. The actual loss on the Announced Arysta Sale will be dependent on a number of factors, including foreign exchange rates on the closing date of the sale and other closing adjustments.

The Announced Arysta Sale is currently targeted to close on December 31, 2018, although the timing will be subject to customary closing conditions including receipt of outstanding regulatory clearances. Several key antitrust approvals have already been received, including in Brazil, Colombia, South Africa and the United States (Hart-Scott-Rodino Act, or HSR).

#### Conditional Board Approval of Share Repurchases of up to $750 million

The proceeds of the Announced Arysta Sale are expected to be used primarily to pay down a portion of our existing debt. We also may repurchase shares of our common stock in accordance with the previously-announced share repurchases program of up to $750 million approved by the Board, conditioned upon the closing of the Announced Arysta Sale. The timing, method and ultimate amount of any share repurchases cannot be determined at this time.

#### Intended Company Name Change

In connection with the Announced Arysta Sale, we announced our plan to change the name of the Company to Element Solutions Inc, effective at closing. We expect our shares of common stock to be traded on the NYSE under the ticker symbol “NYSE:ESI.”

### Recent Accounting Pronouncements

A summary of recent accounting pronouncements is included in Note 2, *Recent Accounting Pronouncements*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

### Results of Operations

### Three and nine months ended September 30, 2018 as compared to the three and nine months ended September 30, 2017

The following table summarizes our results from continuing operations for the three and nine months ended September 30, 2018 and 2017:

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Net sales** | $488.5 | $480.6 | 2% | 4% | 3% | $1,482.6 | $1,390.0 | 7% | 4% | 4% |
| Cost of sales | 278.9 | 272.4 | 2% | 5% |  | 847.2 | 788.4 | 7% | 5% |  |
| **Gross profit** | 209.6 | 208.2 | 1% | 3% |  | 635.4 | 601.6 | 6% | 3% |  |
| Selling, technical, general and administrative | 139.5 | 140.2 | —% | 1% |  | 424.6 | 420.2 | 1% | (1)% |  |
| Research and development | 10.5 | 11.2 | (6)% | (6)% |  | 33.1 | 33.8 | (2)% | (3)% |  |
| **Operating profit** | 59.6 | 56.8 | 5% | 9% |  | 177.7 | 147.6 | 20% | 17% |  |
| Interest expense, net | (77.9) | (84.7) | (8)% |  |  | (233.4) | (256.3) | (9)% |  |  |
| Foreign exchange (loss) gain | (4.7) | (11.2) | (58)% |  |  | 0.4 | (47.5) | nm |  |  |
| Other (expense) income, net | (0.1) | 0.6 | nm |  |  | 13.6 | 3.4 | nm |  |  |
| Income tax benefit (expense) | 18.8 | 1.6 | nm |  |  | (21.1) | (20.2) | 4% |  |  |
| **Net loss from continuing operations** | (4.3) | (36.9) | (88)% |  |  | $(62.8) | $(173.0) | (64)% |  |  |
| (Loss) income from discontinued operations, net of tax | (401.6) | (29.4) | nm |  |  | (293.3) | 23.1 | nm |  |  |
| **Net loss** | $(405.9) | $(66.3) | nm |  |  | $(356.1) | $(149.9) | nm |  |  |

#### (nm) Calculation not meaningful.

### Non-GAAP Financial Measures

To supplement our financial results presented in accordance with GAAP in this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain non-GAAP financial measures, such as operating results on a constant currency and organic basis. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis in terms of absolute performance, trends and expected future performance with respect to our business. We believe these non-GAAP financial measures, which are each further described below, provide investors with an additional perspective on trends and underlying operating results on a period-to-period comparable basis. We also believe that investors find this information helpful in understanding the ongoing performance of our operations separate from items that may have a disproportionate positive or negative impact on our financial results in any particular period.

These non-GAAP financial measures, however, have limitations as analytical tools, and should not be considered in isolation from, or a substitute for, or superior to, the related financial information that we report in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements, and may not be comparable to similarly titled measures of other companies due to potential differences in calculation methods. In addition, these measures are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded or included in determining these non-GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to their most comparable GAAP financial measures included in this Quarterly Report, and not to rely on any single financial measure to evaluate our business.

### Constant Currency

We disclose operating results from net sales through operating profit on a constant currency basis by adjusting to exclude the impact of changes due to the translation of foreign currencies of our international locations into U.S. dollars. Management believes this non-GAAP financial information facilitates period-to-period comparison in the analysis of trends in business performance, thereby providing valuable supplemental information regarding our results of operations, consistent with how we evaluate our financial results internally.

The impact of foreign currency translation is calculated by converting our current-period local currency financial results into U.S. dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The difference between actual growth rates and constant currency growth rates represents the impact of foreign currency translation. The foreign exchange impacts on the quarter-to-date results were primarily the result of depreciation in the Brazilian real and Chinese yuan, while the impacts on the year-to-date results were primarily the result of appreciation in the euro, Chinese yuan and British pound, partially offset by depreciation in the Brazilian real.

### Organic Net Sales Growth

Organic sales growth is defined as net sales excluding the impact of foreign currency translation, changes due to pass-through pricing of certain metals, and acquisitions and/ or divestitures, as applicable. Management believes this non-GAAP financial measure provides investors with a more complete understanding of the underlying net sales trends by providing comparable sales over differing periods on a consistent basis.

The following table reconciles GAAP net sales growth to organic net sales growth for the three and nine months ended September 30, 2018:

*Three Months Ended September 30, 2018*

| Reported Net Sales Growth | Impact of Currency | Change in Pass-Through Metals Pricing | Acquisitions/ (Divestitures) | Organic Sales Growth |
| ---: | ---: | ---: | ---: | ---: |
| 2% | 2% | —% | —% | 3% |
| **Nine Months Ended September 30, 2018** |  |  |  |  |
| **Reported Net Sales Growth** | **Impact of Currency** | **Change in Pass-Through Metals Pricing** | **Acquisitions/ (Divestitures)** | **Organic Sales Growth** |
| 7% | (3)% | —% | —% | 4% |

#### NOTE: totals may not sum due to rounding

For the three months ended September 30, 2018, pass-through metals pricing had a positive impact of $0.6 million and acquisitions had a positive impact of $2.3 million on net sales.

For the nine months ended September 30, 2018, pass-through metals pricing had a negative impact of $2.0 million and acquisitions had a positive impact of $3.5 million on net sales.

### Net Sales

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Net sales** | $488.5 | $480.6 | 2% | 4% | 3% | $1,482.6 | $1,390.0 | 7% | 4% | 4% |

Net sales in the third quarter of 2018 increased by 2% (4% on a constant currency and 3% on an organic basis). Organic net sales increased across all of our businesses, driven largely by our Industrial business. Industrial Solutions contributed to the segment's organic sales growth primarily through favorable commodity pricing in the Americas and strong demand for core industrial and Fernox products in Europe, partially offset by lower demand in the automotive markets. Organic growth in our Electronics business, which was mostly driven by memory disk and semi-conductor products, was partially offset by lower core sales in Asia. We also saw moderate organic growth in our Assembly business, driven primarily by favorable pricing in bar and wire products in the Americas and Europe, which offset volume softness in Asia. Our Graphics business benefited modestly from strong sales in Latin America and Asia, which were partially offset by declines in the North America. Demand in our Offshore business benefited from improved business conditions in offshore drilling markets and higher fill activity in the period, particularly in the Americas.

On a year-to-date basis, net sales increased by 7% (4% on a constant currency and organic basis). Organic sales growth in our Industrial business benefited from strong growth of surface treatment chemistries in Europe, film products in the Americas and global growth in our Fernox products. Organic sales growth in our Assembly business contributed broadly across product lines, particularly solder paste and bar products in Asia and the Americas. Our Offshore businesses contributed gains primarily from the Americas. Growth in our Electronics business was driven primarily by higher semiconductor and core electronics sales volume in North America.

### Gross Profit

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Gross profit** | $209.6 | $208.2 | 1% | 3% | $635.4 | $601.6 | 6% | 3% |
| **Gross margin** | 42.9% | 43.3% | (40) bps | (40) bps | 42.9% | 43.3% | (40) bps | (30) bps |

Gross profit in the third quarter of 2018 increased by 1% (3% at constant currency). Constant currency growth was driven primarily by higher revenues as discussed above. This growth was partially offset by unfavorable product mix in our Electronics business, which recorded a lower proportion of high-margin product sales, most notably in Korea.

On a year-to-date basis, gross profit increased by 6% (3% at constant currency). The primary driver of the increase in constant currency gross profit and gross margin was an increase in the year-to-date sales growth as discussed above. This growth was partially offset by margin decline resulting primarily from unfavorable product mix in our Electronics and Industrial businesses which recorded a lower proportion of high-margin product sales, the impact of certain raw material price inflation year-over-year and increases in logistics and warehousing costs resulting from our plant rationalization initiatives.

### Selling, Technical, General and Administrative Expense (STG&A)

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **STG&A** | $139.5 | $140.2 | —% | 1% | $424.6 | $420.2 | 1% | (1)% |
| **STG&A as a % of net sales** | 28.5% | 29.1% | (60) bps | (80) bps | 28.6% | 30.2% | (160) bps | (140) bps |

STG&A in the third quarter of 2018 remained relatively unchanged (increased 1% at constant currency). On a constant currency basis, the cost increase was primarily due to higher integration costs, partially offset by lower restructuring.

On a year-to-date basis, STG&A increased by 1% (decreased 1% at constant currency). The decrease in constant currency STG&A expense was the result of lower costs associated with our restructuring actions, partially offset by increased integration costs, operating cost inflation and higher selling costs.

### Research and Development Expense (R&D)

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **R&D** | $10.5 | $11.2 | (6)% | (6)% | $33.1 | $33.8 | (2)% | (3)% |
| **R&D as a % of net sales** | 2.2% | 2.4% | (20) bps | (20) bps | 2.2% | 2.4% | (20) bps | (20) bps |

### Operating Profit

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Operating profit** | $59.6 | $56.8 | 5% | 9% | $177.7 | $147.6 | 20% | 17% |
| **Operating margin** | 12.2% | 11.8% | 40 bps | 60 bps | 12.0% | 10.6% | 140 bps | 130 bps |

Operating profit in the third quarter of 2018 increased by 5% (9% at constant currency), representing an operating margin of 12.2%. The increase in constant currency operating profit and margin was driven primarily by the higher gross profit noted above.

On a year-to-date basis, operating profit increased by 20% (17% at constant currency) to an operating margin of 12.0%. The increase in constant currency operating profit and margin was driven primarily by higher gross profit and lower operating expenses, as noted above.

### Total Other (Expense) Income

*(amounts in millions)*

| Other (expense) income | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Interest expense, net | $(77.9) | $(84.7) | $(233.4) | $(256.3) |
| Foreign exchange (loss) gain | (4.7) | (11.2) | 0.4 | (47.5) |
| Other (expense) income, net | (0.1) | 0.6 | 13.6 | 3.4 |
| **Total** | $(82.7) | $(95.3) | $(219.4) | $(300.4) |

#### Interest Expense, Net

For the three and nine months ended September 30, 2018, net interest expense decreased $6.8 million and $22.9 million, respectively. The decrease in net interest expense, both in the quarter and year-to-date, was primarily driven by the redemption of our 10.375% senior notes and the repricing of a portion of our term loans in 2017, which decreased the weighted average effective interest rate on our Senior Notes from approximately 7.8% at September 30, 2017 to 6.5% at September 30, 2018, and on our term loans from approximately 5.0% at September 30, 2017 to 4.7% at September 30, 2018.

#### Foreign Exchange (Loss) Gain

For the three months ended September 30, 2018 and 2017, foreign exchange loss totaled $4.7 million and $11.2 million, respectively. For the nine months ended September 30, 2018 and 2017, foreign exchange gain (loss) totaled $0.4 million and $(47.5) million, respectively. The change in foreign exchange losses and gains for both periods presented was primarily related to the remeasurement of British pound and Taiwan dollar denominated intercompany balances and euro-denominated debt to U.S. dollar.

#### Other (Expense) Income, Net

For the nine months ended September 30, 2018 and 2017, other income, net totaled $13.6 million and $3.4 million, respectively. The year-to-date change was primarily related to a gain on the sale of an equity investment of $11.3 million. Prior year activity included a favorable legal settlement of $10.6 million, which was largely offset by $7.8 million of debt extinguishment costs.

### Income Tax

*(amounts in millions)*

| Income tax | Three Months Ended September 30, 2018 | 2017 | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: | ---: | ---: |
| Income tax benefit (expense) | $18.8 | $1.6 | $(21.1) | $(20.2) |
| Effective tax rate | 81.4% | 4.2% | (50.6)% | (13.2)% |

For the three months ended September 30, 2018 and 2017, income tax benefit totaled $18.8 million and $1.6 million, respectively. The income tax benefit in 2018 is driven by anticipated costs associated with the recapitalization of our balance sheet arising from the Announced Arysta Sale. These costs impact our quarterly tax provision as it is based on full year expected earnings by jurisdiction and were not included in the expected earnings of previous quarters.

For the nine months ended September 30, 2018 and 2017, income tax expense totaled $21.1 million and $20.2 million, respectively. The change in the effective tax rate is primarily due to a reduction in losses and a corresponding change in recognition of valuation allowances on net operating losses that may not be recoverable in jurisdictions resulting in no tax impact.

### (Loss) Income from Discontinued Operations, Net of Tax

Loss from discontinued operations, net of tax, for the three months ended September 30, 2018 totaled $402 million, as compared to a net loss of $29.4 million in the prior year. For the nine months ended September 30, 2018, loss from discontinued operations, net of tax, totaled $293 million, compared to net income of $23.1 million in the prior year. The increased loss in both periods was driven by an estimated impairment of $376 million which primarily reflected the recognition of foreign currency translation adjustments recorded in "Accumulated Other Comprehensive Loss" within Stockholders’ Equity.

### Other Comprehensive (Loss) Income

Other comprehensive loss for the three months ended September 30, 2018 totaled $92.0 million, as compared to income of $129 million in the prior year. The change was driven primarily by foreign currency translation losses associated with the Brazilian real, Chinese yuan and euro partially offset by gains associated with the British pound.

For the nine months ended September 30, 2018, other comprehensive loss totaled $402 million, compared to income of $270 million in the prior year. The change was driven primarily by foreign currency translation losses associated with the Brazilian real, Chinese yuan, euro and Canadian dollar partially offset by gains associated with the British pound.

### Segment Performance

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. As discussed in Note 4, *Discontinued Operations*, to our unaudited interim Condensed Consolidated Financial Statements, included in this Quarterly Report, in the three months ended September 30, 2018, the Agricultural Solutions segment met the requirements to be classified as discontinued operations. As a result, the Agricultural Solutions' operations have been excluded from the segment discussion below. For additional information regarding our segments, see Part I, Item 2, *Management’s Discussion and Analysis of Financial Condition and Results of Operations*, under "*Overview,*" and Notes 4, *Discontinued Operations,* and 15, *Segment Information,* to our unaudited interim Condensed Consolidated Financial Statements, included in this Quarterly Report.

### Adjusted EBITDA

We utilize Adjusted EBITDA as one of the measures to evaluate the performance. Adjusted EBITDA includes corporate costs, such as compensation expense and professional fees. See Note 15, *Segment Information*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report for more information and a reconciliation of Net loss attributable to common stockholders to Adjusted EBITDA.

*($ amounts in millions)*

|  | Three Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency | Nine Months Ended September 30, 2018 | 2017 | % Change Reported | Constant Currency |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| **Adjusted EBITDA** | 108.3 | 107.8 | 1% | 3% | 321.8 | 297.7 | 8% | 5% |
| **Adjusted EBITDA as a % of net sales** | 22.2% | 22.4% | (20) bps | (20 bps) | 21.7% | 21.4% | 30 bps | 20 bps |

Performance Solutions' Adjusted EBITDA in the third quarter of 2018 increased by 1% (3% at constant currency). The constant currency increase was driven primarily by gross profit growth in our Offshore and Graphics businesses combined with the containment of operating expenses, as noted above. This growth was partially offset by unfavorable product mix in Industrial Solutions.

On a year-to-date basis, Performance Solutions' Adjusted EBITDA increased 8% (5% at constant currency). The constant currency increase and margin expansion was driven primarily by gross profit growth in our Assembly, Offshore and Electronics businesses combined with the containment of operating expenses, as noted above.

### Liquidity and Capital Resources

At September 30, 2018, our indebtedness totaled $5.40 billion, of which $1.31 billion consisted of term loans under our Amended and Restated Credit Agreement which will become due in 2020. As a result of our interest rate swaps, approximately 69% of our debt is fixed, with the remaining balance subject to fluctuations in the one-month LIBOR and EURIBOR. On July 20, 2018, we entered into the Arysta Sale Agreement to sell our Agricultural Solutions business for $4.20 billion in cash, subject to adjustments, the proceeds of which are expected to be used primarily to reduce our existing debt, for which we may incur significant nonrecurring expenses. We may also repurchase shares of our common stock in conjunction with the Board's authorization of up to $750 million in potential share repurchases, conditioned upon the closing of the Announced Arysta Sale. The expected interest payments on our Senior Notes and term loans total approximately $275 million per year over the next two years, prior to any potential use of the expected proceeds from the Announced Arysta Sale and the impact of this sale on our capital structure.

Our primary sources of liquidity during the nine months ended September 30, 2018 were periodic borrowings under our Revolving Credit Facility and available cash generated from operations. Our primary uses of cash and cash equivalents were to fund operations, working capital, capital expenditures and debt service obligations. We believe that our cash and cash equivalents and cash generated from operations, supplemented by availability under our lines of credit, including our Revolving Credit Facility, will be sufficient to meet our working capital needs, interest payments, capital expenditures and other business requirements for at least the next twelve months. However, potential share repurchases or refinancings of our existing debt instruments, working capital cycles and/or future acquisitions may require additional funding, which may include proceeds from the Announced Arysta Sale as well as future debt and/or equity offerings. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt and raise equity under terms that are favorable to us.

During the nine months ended September 30, 2018, approximately 76% of our net sales was generated from non-U.S. operations. We expect to continue to generate significant revenue from non-U.S. operations and, as a result, have a substantial portion of our cash held predominately by our foreign subsidiaries. We expect to manage our worldwide cash requirements based on available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the United States and other international subsidiaries when we believe it is cost effective to do so.

We continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities, which support our current designation of a portion of these funds as being indefinitely reinvested and reassess whether there is a demonstrated need to repatriate funds held internationally. If, as a result of our review, it is determined that all or a portion of the funds require repatriation, we may be required to accrue additional foreign taxes. Of our $252 million of cash and cash equivalents at September 30, 2018, $247 million were held by our foreign subsidiaries.

The following is a summary of our cash flows used in operating, investing, and financing activities of continuing operations during the periods indicated:

*(amounts in millions)*

|  | Nine Months Ended September 30, 2018 | 2017 |
| --- | ---: | ---: |
| Cash used in operating activities | $(26.4) | $(65.0) |
| Cash used in investing activities | $(18.0) | $(14.5) |
| Cash used in financing activities | $(0.8) | $(9.1) |

### Operating Activities

During the nine months ended September 30, 2018, cash used in operating activities totaled $26.4 million, compared to $65.0 million used during the nine months ended September 30, 2017. This $38.6 million decreased use of cash in operating activities was driven primarily by higher cash operating profits (net loss adjusted for non-cash items), including the benefit of $11.2 million of lower interest payments, offset in part by higher payments related to our facility integration initiatives and environmental matters.

### Investing Activities

Cash flows used in investing activities totaled $18.0 million during the nine months ended September 30, 2018, as compared to $14.5 million used during the nine months ended September 30, 2017. The $3.5 million increased use of cash in investing activities was driven by a year-over-year decrease in proceeds from the disposal of fixed assets and a $4.9 million reduction in capital expenditures. During the current year, we received $25.0 million of proceeds from the sale of an equity investment, which was offset in part by $28.2 million of acquisition spending.

### Financing Activities

Cash flows used in financing activities totaled $0.8 million during the nine months ended September 30, 2018, as compared to $9.1 million used during the nine months ended September 30, 2017. This $8.3 million decreased use of cash was primarily driven by $6.1 million of debt extinguishment costs in 2017.

### Financial Borrowings

### Credit Facilities

At September 30, 2018, we had $5.40 billion of indebtedness, which primarily included:

- $2.28 billion of Senior Notes; and
- $3.11 billion of term debt arrangements outstanding under our First Lien Credit Facility.

Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $497 million at September 30, 2018 (net of $16.8 million of stand-by letters of credit which reduce our borrowing capacity).

### Covenants

Our Credit Facilities contain various affirmative and negative covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, and dispositions. Our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters; provided that in the event that the Company or certain of its subsidiaries (i) incur incremental facilities in an aggregate amount in excess of $250 million or (ii) make restricted payments in an aggregate amount in excess of $50 million, the first lien net leverage ratio will be reduced to 4.0 to 1.0, in each case subject to a right to cure. In addition, our Amended and Restated Credit Agreement requires mandatory prepayments in the case of excess cash flow, calculated as set forth in the Amended and Restated Credit Agreement, of 75% with step-downs to 50%, 25% and 0% based on the applicable first lien net leverage ratio on the prepayment date.

Lastly, our Senior Notes are governed by indentures which also provide, among other things, for customary affirmative and negative covenants, events of default, and other customary provisions.

### Off-Balance Sheet Transactions

We use customary off-balance sheet arrangements, such as letters of credit and operating leases.

For additional information regarding letters of credit, see Note 8, *Debt*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

As a result of ASU No. 2016-02, “*Leases,”* we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions beginning on January 1, 2019. For additional information, see Note 2, *Recent Accounting Pronouncements*, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

## Market risk

As filed, 335 characters.

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our 2017 Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our 2017 Annual Report.

## Controls and procedures

As filed, 4,681 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to the previously-reported material weakness in our internal control over financial reporting relating to the accounting for income taxes, as described more fully in Part II, Item 9A, Controls and Procedures, of our 2017 Annual Report.

The material weakness in our internal control relating to the accounting for income taxes continued to exist as of the end of the period covered by this Quarterly Report and our management continues to be actively engaged in implementing the remediation initiatives described in our 2017 Annual Report. Our ongoing remediation efforts to design and implement integrated processes, enhancing our internal controls over the accounting for income taxes, include the implementation of the following previously stated initiatives:

- improving the overall tax provision process by redesigning and updating our policies and procedures;
- enhancing our income tax controls to include specific activities to assess the accounting for significant complex transactions and other tax related judgments;
- deploying training initiatives to incorporate updated policies, processes and controls into standard procedures; and
- aligning staff to reflect the structure and experience levels necessary to execute the enhanced control environment.

While we believe that significant progress continues to be made, additional time is necessary to fully implement and demonstrate the effectiveness of these remediation initiatives and until remediated, the material weakness described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. We are committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary. Our remediation efforts are also subject to ongoing Audit Committee oversight. Our goal continues to be to remediate this material weakness concurrently with the filing of our annual report on Form 10-K for the year ended December 31, 2018.

Notwithstanding the aforementioned material weakness, our management believes that the unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position and cash flows as of and for the periods presented, each in accordance with GAAP. Based in part on our continuing efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.

### (b) Changes to Internal Control Over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no significant changes in our internal control over financial reporting that occurred during the quarter covered by this Quarterly Report that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 4,973 characters.

Except as set forth below, there have been no material changes to the risk factors set forth in Part I, Item 1A of our 2017 Annual Report under the heading “Risk Factors.”

***We and UPL may be unable to obtain the regulatory approvals or satisfy the other closing conditions required to complete the Announced Arysta Sale, which could impact our financial condition, results of operations, prospects and/or stock price.***

The completion of the Announced Arysta Sale is subject to closing conditions, including approvals from antitrust authorities and certain other governmental authorities. We and UPL are pursuing all required consents, clearances and authorizations in accordance with the Arysta Sale Agreement. However, no assurance can be given that the required consents, clearances and authorizations will be obtained and, even if all such consents, clearances and authorizations are obtained, no assurance can be given as to the terms, conditions and timing of the consents, clearances and authorizations. These consents, clearances and authorizations may also impose conditions, which may delay or alter the parties' ability to complete the Announced Arysta Sale.

Further, even if all such consents, clearances and authorizations are obtained and such conditions are satisfied, no assurance can be given that the other conditions required to complete the Announced Arysta Sale will be satisfied, by us or UPL. The Arysta Sale Agreement may also be terminated by us and UPL in certain specified circumstances, including if the closing of the Announced Arysta Sale does not occur on or prior to December 31, 2019, subject to certain extension rights. If the Arysta Sale Agreement is terminated, we may not be able to negotiate another transaction on terms comparable to, or better than, the terms of the Arysta Sale Agreement.

The failure of the Announced Arysta Sale to close on a timely basis, or at all, could have a material adverse effect on our financial condition and/or stock price.

***The announcement and pendency of the closing of the Announced Arysta Sale to UPL could have an adverse effect on our business, results of operations, financial condition, prospects and/or stock price.***

The announcement and pendency of the closing of the Announced Arysta Sale, which is expected to occur late in late 2018 or in early 2019, could disrupt our business and/or our stock price in the following ways, among others:

- our current or prospective customers may experience uncertainty associated with the Announced Arysta Sale and may delay or defer purchase decisions with regard to our products;
- our customers, distributors and lenders may also attempt to terminate and/or renegotiate their relationships with us, whether pursuant to the terms of their existing agreements with us or otherwise;
- uncertainties related to the Announced Arysta Sale may impair our ability to attract, retain and motivate key personnel;
- under the Arysta Sale Agreement, we are subject to certain restrictions on the conduct of our business prior to the closing of the Announced Arysta Sale, which restrictions could adversely affect our ability to realize certain of our business strategies or take advantage of certain business opportunities;
- the current trading price of our common stock may reflect a market assumption that the Announced Arysta Sale will be completed, and may be materially impacted if the closing is delayed or the transaction completed under different, less favorable terms, or if the Arysta Sale Agreement is terminated; and
- the attention of our management may be directed toward the closing of the Announced Arysta Sale and related matters, and their focus may be diverted from the day-to-day business operations of our Company, including from other opportunities that might otherwise be beneficial to us.

***Upon closing of the Announced Arysta Sale, we intend to implement a reorganization, which could negatively impact our performance.***

Upon the closing of the Announced Arysta Sale, we intend to change Platform’s portfolio management approach to a “one-company” structure. This reorganization is expected to remove our “corporate” holding company framework by combining our corporate functions with those of our Performance Solutions segment and creating a single operating unit. This reorganization could disrupt our operations and cause the loss of key personnel. We cannot guarantee that this new company structure will succeed or that we will be effective in executing the reorganization. Further, even if the reorganization is successful, we cannot guarantee that the new company structure will generate the cost savings and efficiencies that we anticipate. Failure to implement the reorganization or the new company structure successfully, on a timely basis, or at all, or failure to realize all, or any, of their intended benefits, may materially adversely affect our business, financial condition or results of operations.

Filed Nov 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001590714-18-000109. Last ingested by Listed: Nov 10, 2026, 23:30 ET. No prices; not investment advice.
